Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYP4F12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CYP4F3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR10H2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR10H3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP4F8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR10H1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CYP4F22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP4F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGLYRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP4F11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WIZ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00661 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on